Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TARGET-EFT Trial (MulTicomponent Acute Intervention in FRail GEriatric PaTients With Cardiovascular Disease Using the Essential Frailty Toolset)

NCT04291690 is registered in ClinicalTrials.gov with Jonathan Afilalo as lead sponsor.

NCT NCT04291690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TARGET-EFT Trial (MulTicomponent Acute Intervention in FRail GEriatric PaTients With Cardiovascular Disease Using the Essential Frailty Toolset)
Lead sponsor
Jonathan Afilalo
Phase
Not applicable
Overall status
Completed
Start date
March 5, 2020
Completion date
September 24, 2021
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases in old age, frailty, geriatric cardiology, quality of life